Specialty benefit vendors have made big promises about lower costs and healthier workers. Employers are now demanding ...

Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

“The drug company wants their drug on the formulary in a favorable position. The PBM wants to get the largest possible rebate.” The “rebate” is the difference between the list price for a ...

CVS and Cigna-owned Express Scripts filed lawsuits ... costs come at a time of governmental scrutiny on prescription drug prices in the US. Looking back on health insurance providers stocks ...

The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices in the US. Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first ...

Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not ...

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...